Skip to main content
. 2018 Mar 27;62(4):e02169-17. doi: 10.1128/AAC.02169-17

TABLE 3.

Pharmacokinetic parameters of lascufloxacin in plasma, ELF, and AMa

Sample Tmax (h) Cmax (μg/ml) AUC0–24 (μg · h/ml) Site-to-plasma Cmax ratio Site-to-free plasma Cmax ratio Site-to-plasma AUC0–24 ratio Site-to-free plasma AUC0–24 ratio
Plasma 1 0.576 7.67
ELF 1 12.3 123 21.4 82.1 16.0 61.7
AM 6 21.8 325 37.8 146 42.4 163
a

Pharmacokinetic parameters were calculated from the mean concentration-time profile of lascufloxacin. ELF, epithelial lining fluid; AM, alveolar macrophages.

HHS Vulnerability Disclosure